61 results about "Hyperthyroids" patented technology

The invention belongs to the technical field of immunodiagnosis, and discloses a thyroxine (T4) enzymatic chemiluminescence quantitative determination kit. The kit disclosed by the invention consists of a T4 standard product, an antibody pre-coated reaction plate, a horseradish peroxidase marker, diluent, cleaning mixture, and chemiluminescence substrate liquid. The kit disclosed by the invention has the advantages of quickness, handiness, sensitiveness, cheapness and high repeatability, and is an important index for diagnosis and therapeutic evaluation of hyperthyroidism and hypothyroidism. The invention has high clinic use value. The invention also provides a method to prepare the kit.

An exterior-applied ointment for treating thyroidism is prepared from glucocorticoid, thyroidism-resistant medicines, percutaneous promoter, oily matrix, water-soluble matrix, and distilled water.

A traditional Chinese medicine composition for treating hyperthyroidism and a preparation method and a use method thereof resolve the problem that the existing traditional Chinese medicine for treating hyperthyroidism does not have common adaptability and is not favorable for industrial production. The composition comprises the following raw materials as effective components: 15-60 parts of astragalus mongholicus, 15-50 parts of radix scrophulariae, 15-60 parts of oyster, 15-50 parts of thunberg fritillary bulb and 10-60 parts of selfheal. The composition changes composition ratio of the raw material medicine according to difference of clinical symptoms of hyperthyroidism, thereby being suitable for the front stage, the middle stage and the later stage of the hyperthyroidism. The composition adopts the start point design- response surface method to optimize process parameter extracted from the effective components of the raw material medicine. The traditional Chinese medicine composition is based on heteropathy in the whole generation and development processes of the disease and has the advantages of being quick, good and high in treatment effect, small in side effect, convenient to take and the like. The disease is not apt to reappear by means of the composition.

The invention relates to compositions for preventing and / or treating cardiovascular diseases in felines with hyperthyroidism wherein the compositions comprise from about 0.07 to less than about 1 mg / kg iodine and / or from about 0.1 to about 1.3 mg / kg selenium. The invention also relates to methods for preparing and using such compositions. articles of manufacture comprising such compositions, and means for communicating information about such compositions. methods, and articles of manufacture.

The invention relates to compositions for preventing chronic renal failure (CRF) in felines with hyperthyroidism wherein the compositions comprise (1) from about 28 to about 35% protein, the protein comprising at least about 75% vegetable protein, and (2) from about 0.1 to less than about 1 mg / kg iodine and / or from about 0.1 to about 1 mg / kg selenium. The invention also relates to compositions for treating CRF in hyperthyroid felines wherein the compositions comprise (1) from about 28 to about 35% protein, the protein comprising at least about 75% vegetable protein, and (2) from about 0.1 to less than about 0.3 mg / kg iodine and / or from about 0.1 to about 1 mg / kg selenium. The invention further relates to methods for preparing and using such compositions, articles of manufacture comprising such compositions, and means for communicating information about such compositions, methods, and articles of manufacture.

The invention relates to a preparation method of an anti-thyroid ointment for external application. The preparation method comprises the following steps: mixing glucocorticoid with a drug carrier material to make the glucocorticoid be evenly dispersed on the drug carrier material; adding an anti-thyroid drug into distilled water, evenly mixing, heating to 80 DEG C, evenly stirring so as to obtain a water phase; heating an oil-soluble substrate and a penetration promoter to a temperature of 80 DEG C so as to melt the substrate and the penetration promoter, evenly mixing the substrate and the penetration promoter so as to obtain an oil phase; pouring the oil phase into the water phase at a constant temperature of 80 DEG C, evenly stirring; adding a glucocorticoid component when the temperature is cooled to 40 DEG C; and finally stirring and cooling so as to obtain an ointment. The drug stability and solubility are improved, and the drug quality, curative effect, and service life are guaranteed and enhanced. The skin adverse reactions are reduced, the patients' paints are prominently reduced, the patients' compliance of drug application is improved, and thus the effect on treating hyperthyroidism is improved. The preparation is stable and safer, has a better curative effect, and is benefit for large-scale promotion and application.

A Chinese medicine for treating thyroidism is prepared from 11 Chinese-medicinal materials including black plum, white peony root, capejasmine fruit, mulberry leaf, etc. Its preparing process is also disclosed.

The invention provides pharmaceutical compositions for improving the bone loss of hyperthyroid high-conversion type and the reduction of the biomechanical properties of the bone, and relates to an extract of a Chinese medicinal Danshen, or the formula and the production process of pharmaceutical compositions for improving the bone loss of high-conversion type and the reduction of the biomechanicalproperties of the bone caused by the hypersplenism of the thyroid, which is prepared from the following components in parts by weight: 0.1 to 0.3 g of a danshensu and 5 g of crystalline fructose, thepharmaceutical compositions are characterized by being prepared into an injection. The invention further discloses a formula and production process of the injection, a granule and a non-alcoholic beverage. The high-dose thyroxine-induced hyperthyroid high-conversion bone loss animal model proves that the pharmaceutical composition prepared from the danshensu and the fructose can influence the bone metabolism of the rat, promote the bone formation, inhibit the bone resorption, increase the bone mass, improve the bone mineral density and the bone mineral salt content, and improve the performance of the bone biomechanics, and has a good preventive effect on the damage of the bone biological biomechanical properties of the hyperthyroid osteoporosis.

The invention relates to an injection medicament for treating hyperthyroid, which comprises the following components by weight part: 2 to 5 milligrams of dexamethasone injection, 0.5 to 1 milligram of octreotide injection, and 10 to 20 milligrams of ciclosporin A. Immune preparations such as the dexamethasone injection, the octreotide injection, the ciclosporin A and the like are adopted for treating the hyperthyroid by locally injecting the thyroid, the volume of the tumid thyroid is remarkably shrunk, and the function of the thyroid basically recovers within two months, so the injection medicament has remarkable curative effect, and can remarkably improve the remission rate of hyperthyroid and reduce the rate of relapse. Serious abnormal change, hypothyroidism and parathyroid hypofunction are not caused, and laryngeal recurrent nerve injury is also not caused. Through more than 580 cases of clinical therapy in related hospitals, the volume of the tumid thyroid is remarkably shrunk after therapy, clinical symptoms disappear, allergic response and complications are not caused, the effective percentage is nearly 100 percent, and the cure rate is as high as 98 percent.

The invention discloses traditional Chinese medicine composition medicinal liquor for treating hyperthyroidism. The medicinal liquor is mainly prepared from the following raw material medicines in parts by weight: 10-20 parts of angelica sinensis, 6-10 parts of safflower, 2-4 parts of potassium iodide (added at end), 18-25 parts of rock candy (added at end), 9-16 parts of white paeony root, 10-15 parts of uncaria, 9-15 parts of concha haliotidis, 10-20 parts of eucommia ulmoides, 10-20 parts of dogwood, 8-16 parts of radices trichosanthis, 10-20 parts of dried tangerine or orange peel, 8-16 parts of Winged Laggera Herb, 9-16 parts of jews marro, 8-15 parts of rhizoma pinelliae preparata, 9-15 parts of kelp, 8-12 parts of seaweed, 8-12 parts of oyster, 10-20 parts of wolfberry, 6-12 parts of selfheal and 6-12 parts of thunberg fritillary bulb. The traditional Chinese medicine composition medicinal liquor provided by the invention has the effects of clearing heat and calming the liver, nourishing kidney and improving eyesight and tonifying middle-Jiao and Qi and is high in clinical cure rate.

The invention discloses a traditional Chinese medicine preparation for treating hyperthyreosis and a preparation process thereof. The traditional Chinese medicine preparation is prepared from the following main medicinal raw materials in parts by weight: 10-20 parts of fructus amomi, 8-15 parts of eucommia ulmoides, 6-9 parts of herba fibraureae recisae, 5-10 parts of jews marro, 10-15 parts of raspberry, 10-20 parts of fermented soybean, 5-10 parts of fried nux prinsepiae, 15-20 parts of fried spina date seed, 9-16 parts of raw semen cuscutae, 8-12 parts of rhizoma pinelliae preparata, 8-12 parts of fritillary bulb, 8-12 parts of seaweed, 5-10 parts of raw oyster, 10-20 parts of angelica, 10-20 parts of yam, 9-16 parts of pericarpium citri reticulatae, 8-12 parts of safflower, 7-15 parts of dogwood, 10-20 parts of radix trichosanthis and 15-20 parts of semen boitae. The traditional Chinese medicine preparation disclosed by the invention is safe and effective, free of adverse reactions, and capable of avoiding recurrence, effectively eliminating or relieving clinical symptoms of hyperthyroidism and conditioning integral organism function.

The invention provides a traditional Chinese medicine composition for treating hyperthyroidism and a preparation method thereof. The traditional Chinese medicine composition comprises the following raw medicinal materials: radix aristolochiae, clam shell, dried tangerine or orange peel, sea-tangle, marine algae, cuttlebone, air potato, seed of feather cockscomb, radix bupleuri, rhizoma cyperi, radix paeoniae alba, ligusticum wallichii, pericarpium citri reticulatae viride, pinellia ternate, wild amaranth, clematis apiifoli, sargentodoxa cuneata, native copper, selfheal spike, rhizoma dioscoreae nipponicae, cretinism drug, nemacystus, valerian and nogra merr. The traditional Chinese medicine composition has the following beneficial effects: according to the traditional theory of traditional Chinese medicine in our country, the traditional Chinese medicines in the composition have functions in softening hardness to dissipate stagnation, promoting blood circulation to remove blood stasis, smoothing liver-qi stagnation, regulating qi-flowing for eliminating phlegm, by adoption of the composition, the internal secretion can be regulated, the immunity is improved, the normal function of a thyroid can be recovered, therefore the traditional Chinese medicine composition has advantages of fast acting, significant effect, high security, no side and toxic effect and less recurrence in the treatment of hyperthyroidism.

The invention discloses a chemiluminescence immunoassay kit for quantitative detection of a soluble intercellular adhesion molecule-1 and a detection method. The kit contains a 96-well plate which is pre-coated with an anti-intercellular adhesion molecule-1 monoclonal antibody and the following bottled reagents: a phosphate wash solution, a blocking solution, a sample dilution solution, an intercellular adhesion molecule-1 standard solution, a horseradish peroxidase-labeled anti-intercellular adhesion molecule-1 polyclonal antibody IgG and a luminescent substrate, namely a luminal luminescent solution and quality control serum. The kit disclosed by the invention has the advantages of accurate and objective determination result of the soluble intercellular adhesion molecule-1 in human serum, simple and convenient method and easiness in popularization and application. The kit can reflect the autoimmune state in a patient with autoimmune thyroid disease can be used as a reference index for diagnosis of the autoimmune thyroid disease, and further has important significance for understanding the autoimmune active degree, predicting the occurrence of Graves disease and the recurrence of Graves hyperthyroidism, and determining reasonable treatment source, drug withdrawal time and other aspects.

The invention belongs to the field of medicines, and relates to a traditional Chinese medicinal composition for treating hyperthyroidism, and a preparation method and application thereof. The traditional Chinese medicinal composition is prepared from the following traditional Chinese medicinal materials in parts by weight: 10-20 parts of morinda officinalis, 12-18 parts of sculellaria barbata, 6-10 parts of semen cassiae, 10-15 parts of paniculate swallowwort root, 10-20 parts of ligusticum wallichii, 12-16 parts of wild chrysanthemum flower, 6-9 parts of salviae miltiorrhizae, 20-30 parts of momordica grosvenori, 20-30 parts of astragalus membranaceus, 10-16 parts of radix bupleuri, 12-18 parts of poria cocos, 15-25 parts of scutellaria baicalensis, 10-20 parts of tribulusterrestris, 6-12 parts of radix paeoniae alba, 15-20 parts of rhizoma atractylodis macrocephalae and 10-15 parts of liquorice. The traditional Chinese medicinal composition has the advantages of exact curative effect and low side effect when being used for treating hyperthyroidism.

The present invention provides application of Chinese medicine composition in preparation of hyperthyroidism treatment drug. The Chinese medicine composition is composed of Radix Ginseng, lilyturf root, skunk bush, Radix Salivae Miltiorrhizae, parched Semen Ziziphi Spinosae, loranthus, Radix Paeoniae Rubra, Eupolyphaga Seu Steleophaga and Radix Et Rhizoma Nardostachyos. Clinical experiments confirm the Chinese medicine composition has significant clinical therapeutic effect for hyperthyroidism.

Method for obtaining an antibody or antibody fragment to a conformational epitope specific for oxidized, inactive human parathyroid hormone and fragments thereof; a method for removal of oxidized, inactive human parathyroid hormone from a sample of body fluid; methods of determining the concentration of active parathyroid hormone in a sample, and an in vitro method of diagnosis of renal failure or secondary hyperthyroidism in patients on dialysis. The antibody is obtained by immunizing an animal with an immunogen containing parathyroid hormone or fragment thereof oxidized at methionines at positions 8, 18 or both; and a recovering of antibodies; whereby the complementary determining region of the antibody or antibody fragment or single chain antibody specifically recognizes a conformational epitope (antigenic determinant) which is a tertiary structure and only present on oxidized parathyroid hormone and fragments thereof only but not regular bioactive human parathyroid hormone, while the binding surface to the complementary binding region does not include any one of the oxidized methionines of human parathyroid hormone.

The invention discloses medicinal liquor suitable for being drunk by patients with hyperthyroidism. The medicinal liquor is characterized by being prepared from the following raw material medicines in parts by weight: 9-12 parts of codonopsis pilosula, 8-14 parts of ginseng, 15-20 parts of angelica sinensis, 6-9 parts of safflower carthamus, 15-25 parts of pericarpium citri reticulatae, 9-16 parts of rhizoma pinelliae preparata, 8-12 parts of kelp, 2-4 parts of potassium iodide (added later), 10-20 parts of crystal sugar (added later), 15-20 parts of platycladi seeds, 9-16 parts of galangal, 9-16 parts of cistanche, 10-20 parts of cape jasmine, 8-12 parts of herba fibraureae recisae, 9-14 parts of ternate buttercup root, 10-16 parts of bergamot, 10-20 parts of radix polygonati officinalis, 9-15 parts of perilla stem, 8-12 parts of seaweed, 8-12 parts of raw oyster shells and 15-30 parts of wolfberry. The excellent effects of the medicinal liquor disclosed by the invention are further expressed as follows: the traditional medicine properties are organically combined with the traditional Chinese medicine modern pharmacology, the medicines are used for forming a prescription, and the curative effect is enhanced; the medicines of the medicinal liquor disclosed by the invention have the effects of soothing liver and strengthening spleen, clearing heat and relieving pain, and tonifying middle-jiao and qi, and are exact in curative effect on hyperthyroidism and free from side effects; the medicinal liquor disclosed by the invention is easily available in medicine source, low in medicinal material cost, and capable of reducing the burdens of the patients.

The invention relates to methimazole microemulsion, methimazole microemulsion-based gel and a preparation method and application of the methimazole microemulsion. The methimazole microemulsion comprises methimazole, oil, surfactant, cosurfactant, water and transdermal Enhancer according to a weight ratio of 1:(1.40-4.25):(5.13-15.45):(5.13-15.45):(1.40-8.32):(0.26:1.26). The methimazole microemulsion-based gel is prepared by adding gel matrix into the methimazole microemulsion, allowing swelling and performing uniform mixing. The methimazole microemulsion and the methimazole microemulsion-based gel are directly applicable to affected parts, are also applicable to the preparation of hyperthyroidism pharmaceuticals such as patches or plasters, and have the advantages such as good solubility, high penetration capacity, long acting time, evident improvement in therapeutic effect, fewer times of administration, and convenience of administration.

The invention belongs to the field of medicines, and discloses application of methimazole in serving as and / or preparation of a metal beta-lactamase inhibitor. The invention discloses the application of the methimazole and / or the derivative thereof in serving as and / or preparation of the metal beta-lactamase inhibitor for the first time, the methimazole and / or the derivative thereof has a good inhibition effect on metal beta-lactamase, can protect antibiotics from being degraded by bacteria, improves the sensitivity of the bacteria to the antibiotics, and reversing drug resistance of the bacteria to the antibiotics; and meanwhile, the methimazole and / or the derivative thereof have a good synergistic effect when being combined with the antibiotics, and can be used as an adjuvant drug for inhibiting the bacteria. The methimazole has small toxic and side effects on human bodies under normal clinical use dosage, and has good safety in many years when being clinically used as a medicine for treating hyperthyroidism.

The invention discloses a traditional Chinese medicine preparation for treating hyperthyroid heart diseases. Traditional Chinese doctors believe that hyperthyroid heart diseases belong to the categories of goiter and palpitation. Though the disease location of hyperthyroid heart diseases is heart, hyperthyroid heart diseases are caused by goiter and are frequently suffered by people having extreme changes of emotions; the traditional Chinese medicines including rhizome of longspurred fairybells, pedicularis muscicola, Japanese angelica tree root bark, dewberryleaf cinquefoil herb, albizia flower, marigold, catharanthus roseus, amethyst, rose and arabian jasmine flower and having the effects of tonifying qi, nourishing yin, calming nerves and soothing liver-qi stagnation are decocted with water to form decoction; found from clinical tests, the total effective rate is 95.6%; the traditional Chinese medicine preparation for treating hyperthyroid heart diseases is obvious in curative effect, low in treatment cost and simple and convenient in method and is worthy of being popularized and applied clinically.

The invention provides a new application of lamotrigine in a medicine for treating thyroid dysfunction diseases. Lamotrigine can treat thyroid dysfunction and promote thyroid function indexes to recover to a normal range; on one hand, the lamotrigine is good in safety, and even if the lamotrigine is taken for a long time, the lamotrigine does not cause adverse reaction or thyroid damage like an anti-hyperthyroidism medicine, so that the lifelong hypothyroidism is More importantly, lamotrigine can cure abnormal onychomycosis, so that a patient can be cured and the drug is stopped, and thyroxine is not required to be used for the lifetime like conventional hypothyroidism treatment. Even for patients who suffer from basic diseases (such as diabetes) and simultaneously suffer from thyroidism, the regulating and improving effects of lamotrigine on thyroidism are not obviously influenced by drugs for treating basic diseases, and the patients can take the drugs at the same time, so that the treatment effect of lamotrigine on thyroidism is greatly improved, and the treatment effect of lamotrigine on thyroidism is improved. And the effects of treating abnormal nail function and finally stopping medicine taking can be achieved.

The invention provides a pharmaceutical composition for treating hyperthyroidism. The pharmaceutical composition for treating the hyperthyroidism is prepared from, by weight, 10-20 parts of thunberg fritillary bulbs, 15-30 parts of calcined oyster shells, 15-30 parts of common selfheal fruit-spike, 10-20 parts of sparganii rhizoma, 10-20 parts of citron fruits, 10-20 parts of kelp, 6-15 parts of seaweed, 15-25 parts of salviae miltiorrhizae, 16-28 parts of rhizoma curcumae, 10-25 parts of radix polygoni multiflori, 10-20 parts of concha arcae, 5-15 parts of costustoot, 15-25 parts of rhizoma atractylodis macrocephalae, 20-30 parts of rhizoma alismatis and 15-25 parts of concha mauritiae. According to the pharmaceutical composition for treating the hyperthyroidism, the formula is scientific, the compatibility is proper, toxic and side effects do not exist in clinical application, the curative effect is obvious, and the relapse rate is low.

The invention discloses a traditional Chinese medicine composition for treating hyperthyroidism and belongs to the technical field of medicine for treating hyperthyroidism. The traditional Chinese medicine composition is prepared from, by weight, 10-15 parts of semen raphani, 8-12 parts of white mustard seeds, 3-6 parts of orange peel, 6-9 parts of radix geutianae, 6-9 parts of radix curcumae, 8-12 parts of ophiopogon japonicus, 6-9 parts of seaweed, 6-9 parts of radix seu spiranthis lanceae, 8-12 parts of dandelions, 3-9 parts of wild buckwheat rhizomes, 6-9 parts of caulis trachelospermi, 8-12 parts of Chinese yam, 6-9 parts of Trifolium repens L., 8-12 parts of akebia stems, 10-15 parts of polygala tenuifolia, 3-9 parts of almonds, 8-12 parts of celastrus orbiculatus and 8-12 parts of cortex albiziae. The traditional Chinese medicine composition is prepared from various Chinese herbal medicine in a compatible mode, the medicine effects supplement one another and complement one another, the traditional Chinese medicine composition has the functions of clearing away internal heat and relieving depression, stimulating menstrual flow and dredging channels in a human body, and activating blood to remove stasis, directly reaches a focus, and is used for performing fundamental treatment on hyperthyroidism; the human body immune function of a patient can be enhanced, and the purpose of treating both the current symptoms and the root causes is achieved; the traditional Chinese medicine composition is mild in medicine property, convenient to take, mild and easy to take, free of side effects, short in treatment course and capable of taking effects fast, and hyperthyroidism will not relapse.

The invention provides total-nutrition formula food, specific total-nutrition formula food or non total-nutrition formula food for a patient suffering from hyperthyroidism. The total-nutrition formula food is prepared by integrating research results of advanced physiology, medicines, nutriology, clinical application and the like of the Harvard University at present and combining the physical characteristics of the patient suffering from hyperthyroidism according to requirements of Standard for Food for Special Medical Purpose on the basis of the essence theories of middle warmer regulation, tonifying and balanced nourishing of the conventional traditional Chinese medicine (the main principle is that the three organs, including the liver, the spleen and the kidney, are nourished at the same time). The product is prepared by mixing various medicinal-edible dual-purpose traditional Chinese medicinal extract essences, various probiotics and oligopeptide which serve as main raw materials with prebiotics, carbohydrate, amino acids, various vitamins and mineral substances which serve as auxiliary materials. The total-nutrition formula food can be used as single nutrition for meeting the nutrition demand of the patient suffering from hyperthyroidism and can also achieve the effects of soothing the liver and relieving depression, regulating qi-flowing for eliminating phlegm, activating blood to remove stasis, nourishing yin and tonifying blood, supplementing vitality and enhancing immunity.

The invention discloses a pharmaceutical composition for treating hyperthyroidism and scrofula. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 4-8 parts of radix angelicae lateralis preparata, 1-5 parts of stir-baked squama manitis, 1-4 parts of gleditsia thorn, 1-3 parts of forsythia suspensa, 1-3 parts of frankincense, 1-3 parts of myrrh, 1-5 parts of pollen, 5-10 parts of bupleurum sinenses, 1-3 parts of scutellaria baicalensis, 1-3 parts of pachyrhizua angulatus, 1-3 parts of radix clematidis, 1-3 parts of sapanwood, 2-7 parts of notopterygium roots, 1-3 parts of radix angelicae, 2-5 parts of honeysuckle flowers, 1-3 parts of astragalus lithophilus, 1-5 parts of radix saposhnikoviae, 1-3 parts of concha haliotidis and 1-3 parts of liquorice. The pharmaceutical composition for treating hyperthyroidism and scrofula overcomes the defect of the existing medicine for treating hyperthyroidism and scrofula, and is good in effect.

The invention discloses granules for treating senile hyperthyroidism and a preparation method thereof to solve the problem of treatment of senile hyperthyroidism. The preparation method is characterized by comprising the following steps: (1) decocting welsh onion stalks, adding coarse powder of elaeagnus angustifolia L gum to the decoction, heating the materials until the materials are molten, concentrating the solution, dropping the concentrate into cold water one by one while the concentrate is hot to cool the concentrate, and drying the products in the shade to prepare gum beads for later use; (2) grinding flos citri sarcodactylis, fineleaf schizonepeta herb, common jasminorange leaf and twig and fagopyrum dibotrys stem leaves into powder, and extracting the powder to obtain mixed essential oil; (3) poaching alpinia japonica, fiveleaf akebia fruit, fructus polygoni orientalis, scurrula parasitica, fossil fragments and rhizoma kaempferiae, filtering the solution, concentrating the filtrate, heating the concentrate, and adding and grinding the gum beads obtained in the step 1 to dissolve the gum beads; cooling the solution, adding the mixed essential oil obtained in the step 2, and mixing the materials uniformly to prepare an initial material; (4) drying and grinding the initial material obtained in the step 3 to obtain active granules. Clinical experiments prove that the granules have the characteristics of good curative effects and higher safety in conservatively treating senile hyperthyroidism and are worthy of being clinically applied and popularized.

The invention belongs to the field of medicine, and relates to a traditional Chinese medicine composition for treating hyperthyroidism, a preparation method and application thereof. The traditional Chinese medicine composition is prepared from the following Chinese medicinal materials in parts by weight: 10-20 parts of Morinda officinalis, 12-18 parts of Scutellaria barbata, 6-10 parts of Semen Cassiae, 10-15 parts of Xu Changqing, 10-20 parts of Rhizoma Chuanxiong, 12-16 parts of wild chrysanthemum, 6-9 parts of Salvia miltiorrhiza, 20-30 parts of Luo Han Guo, 20-30 parts of Astragalus, 10-16 parts of Bupleurum, 12-18 parts of Poria cocos, 15-25 parts of Scutellaria baicalensis, 10-20 parts of Tribulus terrestris , 6-12 parts of white peony, 15-20 parts of Atractylodes macrocephala, 10-15 parts of licorice. The traditional Chinese medicine composition has the advantages of definite curative effect and low side effects in treating hyperthyroidism.

The invention discloses a traditional Chinese medicine composition for treating hyperthyroidism. The traditional Chinese medicine composition is composed of common selfheal spike extract and Chinese magnoliavine fruit extract and may be made into any pharmaceutically acceptable oral dosage form, including a tablet, a capsule, a granule, a pill and syrup. According to the invention, the raw materials are simple; cost is reduced compared with other compositions for treating hyperthyroidism; a specific traditional Chinese medicine extraction method is employed, so the recovery rates of effective components in the traditional Chinese medicines are increased; and the traditional Chinese medicine composition has improved treatment effect and small toxic and side effect.